Price
No data yet.
Social Signal Score
Revenue
$26.8KCompany Profile
- CEO
- Yong Qi Quek
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 10
- Beta
- -0.38
- Country
- SG
Financials
CUPR has only 1 quarterly periods on file — the charts below show the full history available.
Revenue
$26.8K+0.0%Net Income
$-2.69MEBITDA
$-2.81MFree Cash Flow
$-3.78MEPS (diluted)
$-1.00Shares Outstanding (diluted)
2.68M+0.0%Operating Expenses
$2.81MCash & Debt
$3.12MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $49.9K | $-4.67M | $-1.84 |
| 2024 | $48.3K | $-1.56M | $-0.57 |
| 2023 | $100.8K | $-1.12M | $-0.41 |
| 2022 | $56.6K | $-1.09M | $-0.43 |
| 2021 | $58.5K | $-519.7K | $-0.20 |
Valuation
CUPRhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80+0.00%Social Signal Score
Mentions (4)
- Newsglobenewswire.com·13d ago·Negative
Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group SINGAPORE, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or the “Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that it has entered into Sale and Purchase Agreements (the “SPAs”) to acquire the entire issued and paid-up share capital of …
View source ↗ - Newsglobenewswire.com·15d ago·Negative
…ng of Underwriter's Over-Allotment Option in Connection with Public Offering SINGAPORE, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that it closed the sale of an additional 648,373 Class A ordinary shares of the Company, pursuant to the full exercise of the underwriter…
View source ↗ - Newsglobenewswire.com·27d ago·Negative
Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering SINGAPORE, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced the closing of its previously announced public offering of an aggregate 4,322,489 Class A Ordinary Shares (“the Offering”) at a price of $1.15 …
View source ↗ - Newsaccessnewswire.com·45d ago·Negative
Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available VANCOUVER, BC / ACCESS Newswire / August 31, 2026 / SUPER COPPER CORP. (CSE:CUPR)(OTCQB:CUPPF)(FSE:N60) ("Super Copper" or the "Company"), is pleased to announce that Zachary Dolesky, Founder and Chief Executive Officer, presented live at the Clean Energy & Metals Virtual Investor Conference on August 27, 2026, the proprietary investor conference series of OTC Markets Group.
View source ↗
Insider trading
Open-market buys and sells by CUPR officers and directors.
No open-market trades in the recent filings. All 7 recent Form 4 entries were share awards, option exercises or tax withholding — pay, not decisions to buy or sell.
7 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in CUPR.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.